When working-age adults develop cardiovascular disease, it often ends up eating up a significant amount of their income. Are insurance companies doing enough to help these patients?
Vascular surgeons play a critical role in today's evolving healthcare landscape. However, researchers noted, they often do not get the respect or appreciation they deserve.
The cardiovascular mortality rate in the United States decreased dramatically from 2000 to 2011. Since then, however, it has remained relatively unchanged.
Its warning pertains to Flexible Cryoprobes, made by Marietta, Georgia-based manufacturer Erbe USA, which may rupture or burst during device activation.
The Columbus, Ohio-based imaging group is repositioning the business to “strengthen brand visibility, clarify service offerings and support long-term growth in an increasingly competitive radiology marketplace.”
Tenaya Therapeutics and Alnylam Pharmaceuticals have agreed to collaborate on identifying potential new gene therapies for the treatment of cardiovascular disease. Tenaya will receive an upfront payment of $10 million, but stands to earn much more.
The new SmartHeart technology automates 14 cardiac views in less than 30 seconds. It was designed to increase productivity and bring more consistency to cardiology and radiology departments.
Back in February, the FDA expanded a recall of several reprocessed EP and ultrasound catheters due to a risk of contamination. The agency is now sharing additional information with the public.
